Spectral Medical Inc. (OTCMKTS:EDTXF - Get Free Report)'s share price shot up 6.3% during mid-day trading on Wednesday . The company traded as high as $0.62 and last traded at $0.61. 58,208 shares changed hands during trading, an increase of 273% from the average session volume of 15,608 shares. The stock had previously closed at $0.57.
Spectral Medical Stock Performance
The firm has a market cap of $174.09 million, a price-to-earnings ratio of -8.72 and a beta of 0.20. The business's 50-day moving average is $0.53 and its 200-day moving average is $0.44.
Spectral Medical (OTCMKTS:EDTXF - Get Free Report) last issued its earnings results on Friday, May 9th. The company reported ($0.03) earnings per share (EPS) for the quarter. The firm had revenue of $0.40 million for the quarter.
About Spectral Medical
(
Get Free Report)
Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream.
Featured Articles
Before you consider Spectral Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spectral Medical wasn't on the list.
While Spectral Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
